# AnPac Bio-Medical Science Co. Ltd. (ANPC)

Source: https://www.quantisnow.com/company/ANPC
Generated: 2026-11-13T00:08:32.529Z

- Ticker: ANPC
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical Specialities
- IPO year: 2020
- Website: anpacbio.com

## About

AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests to corporations and life insurance companies in the People's Republic of China. It offers cancer differentiation analysis devices and physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China.

## Latest ANPC news and filings

- 2024-02-16 21:36 UTC [SEC Form 8-K] [AnPac Bio-Medical Science Co. Ltd. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/anpac-bio-medical-science-co-ltd-filed-sec-form-8-k-entry-5271260)
- 2024-02-01 21:01 UTC [SEC Form 8-K] [AnPac Bio-Medical Science Co. Ltd. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/anpac-bio-medical-science-co-ltd-filed-sec-form-8-k-other-5223567)
- 2024-01-29 22:29 UTC [SEC Form 8-K] [AnPac Bio-Medical Science Co. Ltd. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/anpac-bio-medical-science-co-ltd-filed-sec-form-8-k-entry-5214960)
- 2024-01-29 22:29 UTC [SEC Form 8-K] [AnPac Bio-Medical Science Co. Ltd. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/anpac-bio-medical-science-co-ltd-filed-sec-form-8-k-notice-5214956)
- 2024-01-26 21:31 UTC [SEC Form 3] [SEC Form 3 filed by new insider Liang Zhijun](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-liang-zhijun-5211430)
- 2024-01-26 21:29 UTC [SEC Form 3] [SEC Form 3 filed by new insider Zhao Zhigang](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-zhao-zhigang-5211408)
- 2024-01-26 21:28 UTC [SEC Form 3] [SEC Form 3 filed by new insider Li Xiaoyu](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-li-xiaoyu-5211393)
- 2024-01-26 21:27 UTC [SEC Form 3] [SEC Form 3 filed by new insider Pu Tianruo](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-pu-tianruo-5211392)
- 2024-01-26 21:25 UTC [SEC Form 3] [SEC Form 3 filed by new insider Tian Honggang](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-tian-honggang-5211372)
- 2024-01-16 21:50 UTC [SEC Form 3] [New insider Xu Haohan claimed ownership of 69,774,679 units of Class A Ordinary Shares (SEC Form 3) (Amendment)](https://www.quantisnow.com/insight/new-insider-xu-haohan-claimed-ownership-of-69774679-units-of-5189232)
- 2024-01-09 21:24 UTC [SEC Form 20-F/A filed by AnPac Bio-Medical Science Co. Ltd. (Amendment)](https://www.quantisnow.com/insight/sec-form-20-fa-filed-by-anpac-bio-medical-science-co-ltd-5179427)
- 2024-01-05 21:01 UTC [SEC Form 3] [New insider Xu Haohan claimed ownership of 69,774,949 units of Class A Ordinary Shares (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-xu-haohan-claimed-ownership-of-69774949-units-of-5173059)
- 2023-12-15 21:12 UTC [SEC Form 6-K] [SEC Form 6-K filed by AnPac Bio-Medical Science Co. Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-anpac-bio-medical-science-co-ltd-5140725)
- 2023-12-06 22:26 UTC [SEC Form 6-K] [SEC Form 6-K filed by AnPac Bio-Medical Science Co. Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-anpac-bio-medical-science-co-ltd-5123312)
- 2023-12-06 22:23 UTC [SEC Form 424B5] [SEC Form 424B5 filed by AnPac Bio-Medical Science Co. Ltd.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-anpac-bio-medical-science-co-ltd-5123299)
- 2023-12-04 11:43 UTC [SEC Form 6-K] [SEC Form 6-K filed by AnPac Bio-Medical Science Co. Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-anpac-bio-medical-science-co-ltd-5114998)
- 2023-12-02 02:43 UTC [SEC Form 6-K] [SEC Form 6-K/A filed by AnPac Bio-Medical Science Co. Ltd. (Amendment)](https://www.quantisnow.com/insight/sec-form-6-ka-filed-by-anpac-bio-medical-science-co-ltd-5114917)
- 2023-11-09 22:31 UTC [SEC Form 6-K] [SEC Form 6-K filed by AnPac Bio-Medical Science Co. Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-anpac-bio-medical-science-co-ltd-5076459)
- 2023-10-02 20:01 UTC [SEC Form S-8] [SEC Form S-8 filed by AnPac Bio-Medical Science Co. Ltd.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-anpac-bio-medical-science-co-ltd-4997521)
- 2023-09-25 21:28 UTC [SEC Form 6-K] [SEC Form 6-K filed by AnPac Bio-Medical Science Co. Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-anpac-bio-medical-science-co-ltd-4986857)
- 2023-09-25 13:28 UTC [SEC Form 424B5] [SEC Form 424B5 filed by AnPac Bio-Medical Science Co. Ltd.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-anpac-bio-medical-science-co-ltd-4985898)
- 2023-09-12 20:01 UTC [SEC Form 6-K] [SEC Form 6-K filed by AnPac Bio-Medical Science Co. Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-anpac-bio-medical-science-co-ltd-4966652)
- 2023-08-28 20:01 UTC [SEC Form 6-K] [SEC Form 6-K filed by AnPac Bio-Medical Science Co. Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-anpac-bio-medical-science-co-ltd-4940909)
- 2023-08-21 20:01 UTC [SEC Form 6-K] [SEC Form 6-K filed by AnPac Bio-Medical Science Co. Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-anpac-bio-medical-science-co-ltd-4922543)
- 2023-08-15 20:55 UTC [SEC Form 6-K] [SEC Form 6-K filed by AnPac Bio-Medical Science Co. Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-anpac-bio-medical-science-co-ltd-4902757)
- 2023-07-28 20:02 UTC [SEC Form 6-K] [SEC Form 6-K filed by AnPac Bio-Medical Science Co. Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-anpac-bio-medical-science-co-ltd-4813423)
- 2023-07-28 20:01 UTC [SEC Form 6-K] [SEC Form 6-K filed by AnPac Bio-Medical Science Co. Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-anpac-bio-medical-science-co-ltd-4813404)
- 2023-07-27 20:10 UTC [SEC Schedule 13D] [SEC Form SC 13D filed by AnPac Bio-Medical Science Co. Ltd.](https://www.quantisnow.com/insight/sec-form-sc-13d-filed-by-anpac-bio-medical-science-co-4807385)
- 2023-07-26 20:01 UTC [SEC Form 6-K] [SEC Form 6-K filed by AnPac Bio-Medical Science Co. Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-anpac-bio-medical-science-co-ltd-4799384)
- 2023-07-21 20:18 UTC [SEC Form 6-K] [SEC Form 6-K filed by AnPac Bio-Medical Science Co. Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-anpac-bio-medical-science-co-ltd-4781990)
- 2023-07-21 20:08 UTC [SEC Form 6-K] [SEC Form 6-K filed by AnPac Bio-Medical Science Co. Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-anpac-bio-medical-science-co-ltd-4781877)
- 2023-07-17 10:03 UTC [SEC Form 6-K] [SEC Form 6-K filed by AnPac Bio-Medical Science Co. Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-anpac-bio-medical-science-co-ltd-4758097)
- 2023-07-07 10:14 UTC [SEC Form 6-K] [SEC Form 6-K filed by AnPac Bio-Medical Science Co. Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-anpac-bio-medical-science-co-ltd-4729245)
- 2023-06-15 20:01 UTC [SEC Form 6-K] [SEC Form 6-K filed by AnPac Bio-Medical Science Co. Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-anpac-bio-medical-science-co-ltd-4647930)
- 2023-06-15 20:01 UTC [SEC Form 6-K] [SEC Form 6-K filed by AnPac Bio-Medical Science Co. Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-anpac-bio-medical-science-co-ltd-4647909)
- 2023-05-22 15:28 UTC [SEC Form 424B3] [SEC Form 424B3 filed by AnPac Bio-Medical Science Co. Ltd.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-anpac-bio-medical-science-co-ltd-4538400)
- 2023-05-19 16:55 UTC [Public Offering] [Fresh2 Group Ltd. Announces Nasdaq Ticker Symbol Change from 'ANPC' to 'FRES'](https://www.quantisnow.com/insight/fresh2-group-ltd-announces-nasdaq-ticker-symbol-change-from-anpc-4532384)
- 2023-05-17 20:02 UTC [SEC Form 6-K] [SEC Form 6-K filed by AnPac Bio-Medical Science Co. Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-anpac-bio-medical-science-co-ltd-4521132)
- 2023-05-16 21:00 UTC [Fresh2 Files Annual Report on Form 20-F for Fiscal Year 2022](https://www.quantisnow.com/insight/fresh2-files-annual-report-on-form-20-f-for-fiscal-year-4515760)
- 2023-05-16 20:58 UTC [SEC Form 6-K] [SEC Form 6-K filed by AnPac Bio-Medical Science Co. Ltd.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-anpac-bio-medical-science-co-ltd-4515743)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/ANPC
- Earnings history: https://www.quantisnow.com/earnings/ANPC
- Dividend history: https://www.quantisnow.com/dividends/ANPC
- Insider transactions: https://www.quantisnow.com/insiders/ANPC
- Options chain: https://www.quantisnow.com/options/ANPC
- SEC 8-K filings only: https://www.quantisnow.com/company/ANPC/8-k
- RSS and alerts for ANPC: https://www.quantisnow.com/docs/rss-feeds.md